Novel Amino Derivatives and Carboxamides of Chromen‐2‐one: Synthesis, Antimicrobial Activity, and Molecular Docking Studies

Novel amino derivatives and carboxamides of chromen-2-one were synthesized and evaluated for antimicrobial activity. Compound 9 showed potent antifungal effects, while compounds 10 and 13 were active against the bacteria. Docking studies revealed strong bindng to sterol-14α demethylase and peptide deformylase, supported by multiple sequence alignment analysis.

Abstract

In this study, a series of novel amino derivatives and carboxamides of chromen-2-one were synthesized and screened for their antimicrobial efficacy. Among these, compound 9 was found to be active against all pathogenic Aspergilli and exhibited a minimum inhibitory concentration (MIC) of 15.62 - 31.25 µg/mL in microbroth dilution assay (MDA) and 3.91 µg/disc in disc diffusion assay (DDA). Further, compounds 10 and 13 were found to be active against pathogenic bacteria up to 1.90 µg/disc in DDA. All these active compounds were non-toxic to human erythrocytes up to 1000 µg/mL, whereas the standard drug Amphotericin B lysed all cells at 37.50 µg/mL. The interaction with these antimicrobial results was stimulated by a molecular docking study against the sterol-14 alpha demethylase for Aspergillus fumigatus (PDB ID - 5FRB) and the peptide deformylase for Pseudomonas aeruginosa (PDB ID - 1LRY). Docking showed that compounds 9, 10, and 13 exerted the strongest docking binding values against these proteins. The consistency of the binding affinity was studied using multiple sequence alignment (MSA).

Zum Volltext